Scientific Advisory Board

Pierre is Emeritus Professor of Biochemisty at the University of Strasbourg and Honorary Professor at the Collège de France, Paris. He is the founder and former Director of the Institute for Genetics and Cellular and Molecular Biology (IGBMC, Strasbourg, France) and Institut Clinique de la Souris (MCI, Strasbourg). Pierre has pioneered the structure of eukaryotic genes and their regulation. He received the Albert Lasker Award for Basic Medical Research for his work in this field and the Gairdner Foundation International Award for the discovery of the nuclear receptor superfamily. Pierre is a member of the French, Swedish and US National Academy of Sciences.

Pr. Pierre Chambon

Philippe is Professor of Molecular Immunology, former Chief Executive Officer of the Pasteur Institute of Paris, member of the scientific council of Rhône-Poulenc and Véolia and former Chief Scientific Officer of Pasteur Mérieux Connaught (now Sanofi Pasteur). In addition to his contribution in tumor immunity, Philippe is notably the inventor of cDNA cloning, which was a technological revolution and instrumental for modern Genomics. Philippe is a member of the French Academy of Sciences and Professor at Collège de France, former member of the Singapore Biomedical Sciences International Advisory Council and Chairman of the Singapore Immunology Network.

Pr. Philippe Kourilsky

Dominique is an Emeritus Professor of Surgery at the University Paris XI. Dominique is an internationally recognized expert in liver surgery. Among others, Dominique has pioneered the development liver transplantation in Europe. Former Vice President of the MEDICEN Competitiveness Cluster, President of the French Academy of Surgery, Advisor to the Pasteur Institute, Dominique is also the Chairman of the CellSpace Association, which is committed to build artificial bioengineered liver and other organs.

Pr. Dominique Franco

Maya is Professor of Molecular Virology at the University of Alberta (Canada). Maya is an internationally renowned expert whose work has contributed to the understanding of the biology of reoviruses, having notably improved understanding of the cycle, molecular engineering, production and use of these oncolytic viruses for immunotherapy purposes. She holds the Research Chair in Molecular Virology and Oncotherapy for Canada.

Pr. Maya Shmulevitz

Christian is Professor of Hepatology at Paris Descartes University and is a molecular virologist. Christian’s research work has had breakthrough impact on HBV and HCV chronic infections on liver carcinogenesis as well as on the understanding of the mechanisms of liver regeneration. After heading the Department of Hepatology and an INSERM Unit at the Necker-Enfants Malades Medical Faculty, Christian has served as Chief Executive Officer of INSERM (the French National Institute for Medical Research), Vice President of the Mérieux Institute and then President of the Pasteur Institute of Paris. He is now acting as the President of the Global Virus Network.

Pr. Christian Bréchot

Steve is a former student of Ecole Normale Supérieure of Paris (ENS, France), PhD and molecular immunologist. Steve is the co-founder and former Chief Scientific Officer of the biotechnology company Curevac (Germany). Steve research has been instrumental in demonstrating the potential of messenger RNA for vaccination and has unique experience in this area. Notably, he has implemented the first clinical studies for evaluation of immunotherapies based on direct injection of mRNA. Steve is currently heading a research team in Immunology at the Dermatology Department of the University Hospital of Zürich (Switzerland).

Dr. Steve Pascolo

Jean-Charles is Professor of Hepatology at the University Paris XI and Hepatobiliary Center at Paul Brousse Hospital, Villejuif (France). Jean-Charles is an internationally recognized expert in severe acute and chronic liver diseases. Among others, he is heading the reference center for the management of Wilson’s disease in adulthood and the Departement Hospitalo-Universitaire (DHU) Hepatinov of Assistance Publique – Hôpitaux de Paris, which fosters innovative therapeutic and diagnostic innovative advances for liver diseases care.

Pr. Jean-Charles Duclos-Vallée

Daniel is Research Director at CNRS and is leading the team “Pathophysiological Function of Nuclear Receptor Signaling“ at the Institute of Genetics and Molecular and Cellular Biology (IGBMC, Strasbourg, France). Daniel is an expert in transgenesis and gene regulation by nuclear receptors. Among others, Daniel has co-invented with Pr. Pierre Chambon the Cre-ERT-mediated site-directed cell-specific temporally-controlled somatic mutagenesis method, which is used worldwide to generate genetically modified mice. Daniel is the laureate of the Grand Prix Jules Martin, prix René Turpin of the French Science Academy, and has been awarded by the CNRS Silver Medal. He is also an elected member of the European Academy of Cancer Sciences and of EMBO.

Dr. Daniel Metzger